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Snmmal~ 
The group B Streptococcus, an important cause of invasive infections in the neonate, is dassified 
into four major serotypes (Ia, Ib, II, and III) based on the structure of the polysaccharide capsule. 
Since the capsule is a known virulence factor, it has been extensively studied, in particular in 
type III strains,  which cause the majority of invasive infections. Two cell surface proteins,  a 
and fl, have also been studied in detail since they confer protective immunity, but these proteins 
are usually not expressed by type III strains.  We describe here a cell surface protein, designated 
protein Rib (resistance to proteases, immunity, group B), that confers protective immunity and 
is expressed by most strains of type III. Protein Rib was first identified as a distinct 95-kD protein 
in extracts of a type III strain, and was purified to homogeneity from that strain. Rabbit antiserum 
to protein Rib was used to demonstrate that it is expressed on the cell surface of 31 out of 33 
type III strains,  but only on 1 out of 25 strains representing the other three serotypes. Mouse 
protection tests showed that antiserum to protein Rib protects against lethal infection with three 
different strains expressing this antigen, including a strain representing a recently identified high 
virulence type III clone. Protein Rib is immunologicaUy unrelated to the e~ and fl proteins, but 
shares  several features with  the oe protein.  Most  importantly,  the NH2-terminal amino acid 
sequences of the Rib and o~ proteins are identical at 6 out of 12 positions.  In addition, both 
protein Rib and the a  protein are relatively resistant to trypsin (and Rib is also resistant to pepsin) 
and both proteins vary greatly in size between different clinical isolates.  Finally,  both protein 
Rib and the a  protein exhibit a regular ladderlike pattern in immunoblotting experiments, which 
may reflect a repetitive structure. Taken together, these data suggest that the Rib and ol proteins 
are members of a family of proteins with related structure and function. Since protein Rib confers 
protective immunity, it may be valuable for the development of a protein vaccine against the 
group B Streptococcus,  an encapsulated bacterium. 
D 
uring the last three decades, the group B Streptococcus 
has emerged as a major cause of neonatal disease in the 
Western world. In the United States alone, there  are about 
10,000 cases per year of septicemia, meningitis, and neonatal 
pneumonia caused by this bacterium (1, 2).  These invasive 
infections have an overall mortality of about 20%, and many 
of the infants that survive meningitis have permanent neuro- 
logical sequelae (1, 2). In view of these findings, a large effort 
has been made to analyze the pathogenetic mechanisms in 
group B streptococcal infections, to identify infants at risk, 
and to find methods of prevention and treatment (1-4). 
Group B streptococcal strains are divided into four major 
serotypes (Ia, Ib,  II, and III) based on the structure of the 
polysaccharide capsule (5, 6).  Serotypes I, II, and III occur 
in roughly equal proportions among strains in the normal 
flora, but type III accounts for about two thirds of all iso- 
lates from invasive infections (1). Since the capsule is a known 
virulence factor (1, 5-7), it has been studied in considerable 
detail, in particular in type III strains (1,  7-9).  Efforts are 
under way to develop a vaccine, in which the type III capsule 
would be an essential component (3,  8). 
In addition to the polysaccharide capsule,  some group B 
streptococcal strains also express a cell surface antigen of pro- 
tein nature, the c antigen (10-12).  This antigen is composed 
of at least two polypeptides with unrelated sequences, the 
a  and fl proteins (11-16),  which can be expressed indepen- 
dently of each other (13, 17, 18) and elicit protective immu- 
nity (10,  19,  20).  The o~ protein has recently been shown 
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tance for its biological function (16). The/5 antigen, which 
has also been referred to as protein Bac (14), binds to the 
Fc part of IgA (21, 22),  a property that may allow it to in- 
teract with the immune system of the infected host. Although 
the c~ and/5 proteins confer protective immunity, the avail- 
able evidence indicates  that they are of limited importance 
for group B streptococcal  disease, since they are usually not 
expressed by strains of type III, which cause most cases of 
invasive infections (1). However, it has been suggested that 
a combination of the cr and/5 proteins with the type III poly- 
saccharide may be used as a vaccine against the group B Strep- 
tococcus (11). 
In this report we describe a group B streptococcal  cell sur- 
face protein, designated protein Rib (resistance to proteases, 
immunity, group B),  that elicits  protective immunity and 
is expressed by most strains of type III. Protein Rib is im- 
munologically  unrelated to the ol and/5 proteins, but it shares 
several properties with the c~ protein. 
Materials and Methods 
Bacterial Strains and Media.  Four group B streptococcal strains 
representing the four main capsular serotypes were used as refer- 
ence strains: A909, type Ia (10); SB35, type Ib (22); B1284, type 
II (gift from Dr. C. Schalrn, University of Lund); and BS30, type 
III, described here. The BS30 strain was isolated at Lund Univer- 
sity Hospital from a boy with neonatal infection. A collection of 
58 group B streptococcal strains, all isolated from cases of invasive 
infections, were used to study the expression of cell surface pro- 
teins (see Table 1). 43 of these 58 strains were isolated  from samples 
of blood or cerebrospinal fluid sent to the Clinical Microbiology 
Laboratory of Lund University Hospital during a 5-yr period. Of 
these 43 strains, 29 were of serotype III. Since this series of 43 
strains included only two type II strains, another 11 strains of this 
serotype, obtained from Dr. C. Schalrn, were later added to the 
collection. In addition, four type III strains  of  known electrophoretic 
type (23), obtained from Dr. S. Mattingly (University of  Texas, San 
Antonio, TX), were included among the strains studied. Among 
these four type III strains, two (BM110 and BM122) are members 
of the high-virulence done in phylogenetic division I, and two 
(BM177 and BM181) are members of division II (23). Typing of 
group B streptococcal  strains was performed  in the Clinical  Microbi- 
ology Laboratory of Lund University Hospital, using the coagglu- 
tination technique (24). For several of the strains, the typing was 
kindly confirmed by Dr. N. E. Jensen (State Veterinary Labora- 
tory, Copenhagen, Denmark), using the double diffusion  technique 
with HCl-extracted antigens (25). The SB35sedl strain is a mouse- 
virulent mutant of SB35 showing reduced autoaggregation, pos- 
sibly due to increased  capsule  production (Lindahl, G., unpublished 
results). Three group A streptococcal strains were used: D58X, 
an M3 strain expressing K protein (26), received  from Dr. E. Falsen 
(Culture Collection of the University of Gothenburg, Sweden); 
AL168, an M22 strain (27); and AL368, an M28 strain expressing 
K antigen (27; typing kindly performed by Dr. G. Colman, Cen- 
tral Public Health Laboratory, London, UK). All bacterial strains 
were grown in Todd-Hewitt broth (Oxoid, Basingstoke, Hamp- 
shire, UK) at 37~  without shaking. 
Purification of Protein Rib  The bacteria in a 10-liter overnight 
culture of strain BS30 were spun down, washed twice with 50 mM 
Tris, pH 7.3, and resuspended to 20% (vol/vol) in the same buffer. 
Mutanolysin (Sigma Chemical Co., St. Louis, MO), dissolved to 
5,000 U/ml in 10 mM potassium phosphate, pH 6.2, was then 
added to the bacterial suspension (125 ml) to give a final  concentra- 
tion of 350 U/ml. The digestion was allowed to proceed for 17 h 
at 37~  with gentle shaking, and protease inhibitors were then 
added to the following final  concentrations: benzamidine chloride, 
5 mM; iodoacetic acid, 5 mM; and PMSF, 2 raM. The suspension 
was centrifuged and the supernatant was dialyzed against 10 mM 
Tris, pH 8.0. This dialyzed preparation was immediately subjected 
to two consecutive  steps of  ion exchange  chromatography, a proce- 
dure that allowed the best recovery  of pure protein Rib, as shown 
by preliminary experiments. The presence of protein Rib was ana- 
lyzed by SDS-PAGE and visual inspection of the gels for presence 
of the 95-kD band (see Results). In the first chromatography step, 
the dialyzed  preparation (110 ml) was mixed with the same volume 
of 0.4 M NaC1 in 10 mM Tris, pH 8.0, and 30 ml of DEAE Bin- 
Gel A (Bio-Rad Laboratories, Richmond, CA), equilibrated with 
10 mM Tris, pH 8.0. This mixture was stirred gently at 4~  for 
1 h, and unabsorbed material (containing protein Rib) was recov- 
ered by filtration through a glass filter. For the second chromatog- 
raphy step (see Fig. 2 A), the filtrate containing protein Rib was 
diluted 20-fold with distilled water, to reduce the ionic strength, 
and mixed with 30 ml of DEAE Bio-Gel A, equilibrated as de- 
scribed above. After gentle stirring at 4~  for 16 h, the gel was 
recovered by filtration and washed with 10 mM Tris, pH 8.0. Ab- 
sorbed proteins (including protein Rib) were eluted with an 800- 
ml linear salt gradient (0-0.2 M NaC1 in 10 mM Tris, pH 8.0), 
followed by 1 M NaCI (60 ml). Fractions (10 ml) were collected 
and those containing protein Rib were pooled, concentrated, and 
subjected to gel filtration in a column of Sepharose CL6B (4.2 x 
90 cm) in PBSA (0.12 M NaC1, 0.03 M phosphate, 0.02% NaNa, 
pH 7.2) (see Fig. 2 B). Fractions (10 ml) containing protein Rib 
were pooled and frozen. The yield of protein Rib was about 6 mg 
from 25 g of  bacteria. To ensure the purity of the protein Rib prepa- 
rations used for immunochemical  analysis,  the protein used for such 
work was further purified by SDS-PAGE, followed by electroelu- 
tion of the 95-kD band. However,  SDS-PAGE analysis  did not dem- 
onstrate any difference  in purity between this electroeluted mate- 
rial and that recovered from the gel filtration step. 
Purification of the cr Protein.  The ce protein was purified from 
strain SB35, a type Ib strain expressing  both the ce and fl proteins. 
The procedure used was similar to that used for purification of 
protein Rib from strain BS30. Fractions  were analyzed  for the pres- 
ence of ol protein by dot-blot analysis, using rabbit anti-ol serum 
(kindly provided by Dr. L. Bevanger, University of Trondheim, 
Trondheim, Norway) and protein G (Calbiochem-Novabiochem, 
San Diego, CA) radiolabeled with 125I. In the ion exchange and 
gel filtration steps, the behavior of the cr  protein was similar to 
that of protein Rib (cf Fig. 2) The alpha protein recovered from 
the gel filtration step was present in a sharp peak. Analysis  of this 
material with different antisera indicated that it contained trace 
amounts of contaminating B protein, which was removed  hy pas- 
sage of the preparation through a small column of IgA-Sepharose. 
The purified a  protein had a molecular weight of about 110,000, 
according to SDS-PAGE analysis  (cf Fig. 6). The yield of ce protein 
was 12 mg from 39 g of bacteria. The c~ protein used for im- 
munochemical work was further purified by electroelution from 
SDS-PAGE gels, as described above for protein Rib. 
Purification of the fl Protein (Protein Bac).  The IgA-binding  fl pro- 
tein (21), which has also been referred to as protein Bac (14), was 
previously purified by affinity chromatography on IgA-Sepharose 
(22), but the high cost of this method led to the development of 
another purification method. The starting material was obtained 
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buffer, pH 11.0 (final pH in suspension, 9.7), as described (14, 22). 
The major protein species in such an extract is the 3 protein (22). 
The extract (222  ml) was dialyzed against 10 mM Tris, pH 8.0, 
immediately diluted 20-fold with distilled water, and mixed with 
40 ml of DEAE Bio-Gel A  (equilibrated with  10 mM "Iris, pH 
8.0). After gentle stirring at 4~  for 2 h, the gel was transferred 
to a column and eluted with an 800-ml linear salt gradient (0--0.2 M 
NaC1 in 10 mM Tris, pH 8.0). A dot-blot procedure was used to 
test fractions (10 ml) for presence of B protein, using radiolabeled 
IgA or anti-3 serum and radiolabeled protein G for the analysis. 
The 3 protein was eluted in the first part of the gradient. Appro- 
priate fractions were pooled, concentrated,  and subjected to gel 
filtration on a column (4.2  x  100 cm) ofAcA34 (Pharmacia-LKB, 
Uppsala, Sweden) in PBSA.  The 3  protein was eluted in a well- 
defined peak. Appropriate fractions were pooled, concentrated, and 
frozen. The yield was 9 mg of pure protein from 23 g of bacteria. 
The major protein species in such a preparation had a molecular 
weight  of about  130,000,  according  to  SDS-PAGE,  but  small 
amounts of degradation products of lower molecular weight were 
also seen when the protein was subjected to Western blot analysis 
(cf Fig.  6). 
Analysis of Streptococcal Strains for Cell Surface Expression of the 
oe,/3, and Rib Proteins.  The bacteria in a 10-ml overnight culture 
were washed twice with PBSAT (PBSA supplemented with 0.05% 
Tween 20) and a 1% suspension in PBSAT was prepared. A sample 
(180/A) of this bacterial suspension was mixed with 20 #1 of rabbit 
antiserum that had been diluted in PBSAT, and the mixture was 
incubated at 23~  for 1 h. 2 ml of PBSAT was then added,  the 
bacteria were spun down, washed once with 2 ml of PBSAT, and 
resuspended in 200 #1 of PBSAT. For detection of bound IgG, 25 
#1 of radiolabeled protein G (about 104 cpm in PBSAT) was then 
added, and incubation was continued at 23~  for 1 h. After addi- 
tion of 2 ml of PBSAT, the bacteria were spun down and the Pellet 
was then washed by addition of 2 ml of PBSAT. After a final cen- 
trifugation, the superuatant was discharged and the radioactivity 
in the pellet was determined. Selected strains were tested at different 
antiserum dilutions as indicated (see Fig. 3). When many strains 
were tested for expression of the oe, 3, and Rib proteins (see Table 
1 and Fig. 4), a single final antiserum dilution of 1:1,000 was used. 
This dilution was chosen on the basis of the curves shown in Fig. 
3. Controls with preimmune rabbit antiserum were always included 
and were completely negative in all cases. 
Mouse Protection Tests.  C3H/HeN mice, bred in our department, 
were used  at  an age of 10-20 wk.  The mice were injected  in- 
traperitoneally with 0.1 ml of rabbit serum (diluted with PBS to 
a total volume of 0.5 ml), and infected 4 h later by i.p.  injection 
of 0.5 ml of log-phase bacteria diluted in Todd-Hewitt broth. The 
number of bacteria used, which was estimated to be the 90% le- 
thal dose (LDg0), was 2  x  106 CFU for strains BM110,  BE210, 
and SB35sedI, and 2  x  107 CFU for BS30 and L25. Dead animals 
were counted daily for 4 d. Control animals usually died within 24 h. 
Antisera.  All antisera were produced in rabbits, which were im- 
munized subcutaneously on the back. For preparation of antiserum 
to protein Rib, slices corresponding to several 95-kD bands in SDS- 
PAGE gels were cut out, divided into small pieces, and mixed with 
CFA. For the initial immunization, six slices (about 60/zg of pro- 
tein) in  1 ml of PBS were mixed with  1 ml of adjuvant.  Three 
bands (30/zg of protein) were used for booster injections. The first 
booster was given after 4 wk and three additional boosters were 
given at 2-wk intervals. The rabbit was then bled three times at 
3-wk intervals.  The serum obtained from these three bleedings was 
pooled and used for the experiments reported here. 
Two different antisera to the ot protein were used. The first of 
these anti-~ sera, used for purification of the c~ protein expressed 
by strain SB35, was the kind gift of Dr. L. Bevanger.  The ol pro- 
tein purified from strain SB35 was then used for preparation of 
a second anti-~ serum, used for all experiments reported in this 
paper. The procedure used was similar to that used for preparation 
of antiserum to protein Rib, i.e., slices from SDS-PAGE gels were 
used as antigen, but only two booster injections were given. 2 wk 
after the second booster injection,  the rabbit was exsanguinated 
and the anti-~ serum obtained from this bleeding was used for 
all experiments reported here. Antiserum to the/3 protein was pre- 
pared  from  protein  purified  by  affinity  chromatography  on 
IgA-Sepharose, as described (22). 
Electrophoresis, Western  Blottin~ and Dot-Blot Analysis.  SDS-PAGE 
was performed with standard techniques, using a total polyacryl- 
amide concentration of 10% and a crosslinking of 3.3%. Samples 
were boiled for 3 min in a solution containing 2% SDS and 5% 
2-ME before electrophoresis. The separated proteins were stained 
with Coomassie brilliant blue R-250 or transferred by electroblot- 
ting to a membrane of methanol-activated polyvinylidene difluo- 
ride (Immobilon-P; Millipore Corp., Molsheim, France), using a 
Semi-Dry Electroblotter (Ancos, Vig, Denmark). The Immobilon 
membranes were blocked as described (27) and then incubated with 
the indicated type of rabbit antiserum (diluted 1000-fold),  followed 
by radiolabded protein G and autoradiography, as described (28). 
For dot-blot analysis, samples were applied with a Bio-Dot apparatus 
(Bio-Rad Laboratories) and the Immobilon membranes were ana- 
lyzed with rabbit antiserum and radiolabeled protein G, as described 
above. 
Other Methods.  Small-scale mutanolysin extracts of streptococcal 
strains were prepared as described for the large-scale  extracts used 
for protein purification, but cultures of only 50 ml were used to 
prepare 20% bacterial suspensions,  of which  1-ml samples were 
digested with the enzyme. 
For analysis of protease sensitivity (see Fig.  8), 200-#1 samples 
of purified or, B, or Rib protein (0.5 mg/ml) were incubated for 
1 h at 37~  with trypsin, pepsin, or proteinase K (0.2 mg/ml). 
Trypsin digestion was performed in 0.25 M sodium phosphate, pH 
7.5, pepsin digestion in 0.25 M sodium acetate,  pH 4.0, and pro- 
teinase K digestion in 0.25 M Tris, pH 7.4. The samples were neu- 
tralized before analysis by SDS-PAGE. 
Proteins were radiolabeled  with carrier-free  12sI (Amersham In- 
ternational,  Amersham,  Bucks,  UK),  using  the  chloramine  T 
method (29).  Total protein concentrations were determined with 
a protein assay reagent (MicroBCA; Pierce,  Rockford, IL). Elec- 
troelution of protein from SDS-PAGE  gels was performed with 
an Electro-Eluter (model 422;  Bio-Rad Laboratories). 
Automated amino acid sequence analysis of protein bands trans- 
ferred to Immobilon was performed directly on the membranes, 
using a gas-liquid solid-phase sequenator (model 470A;  Applied 
Biosystems, Inc., Foster City, CA). The membranes were lightly 
stained with Coomassie brilliant blue to localize the protein bands, 
which were then cut out for sequencing.  The SwissProt Data Bank 
was used for analysis  of protein sequences. 
Results 
Identification and Purificatio, of Protein Rib.  While studying 
group  B  streptococcal  cell  surface  proteins,  we  prepared 
mutanolysin extracts of several strains of different serotypes. 
These extracts were analyzed by SDS-PAGE and by immu- 
noblotting,  using antisera to the ot and 3  proteins.  Results 
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group B streptococcal  strains representing  the four main serotypes. The 
positions  of three  proteins  relevant  to this  report are indicated  on the stained 
gel: the a protein (bottom  arrow) and the B protein (top arrow) expressed 
by the strains of types la and Ib, and the 95-kD protein (star) expressed 
by the strain of type III. The rdative positions of the ~ and B proteins 
had been determined  in preliminary  experiments.  The autoradiograms  of 
the blots were deliberately  overexposed, to demonstrate  that the antisera 
to the ~ and B proteins completely  lack reactivity  with extracts of the 
type II and type III strains  used here. The four strains studied  here were 
A909 (type  la), SB35 (type  Ib), B1284 (type  I/), and BS30  (type  III). (Left) 
Molecular mass markers are in kilodaltons. 
obtained with four strains representing the four major sero- 
types are shown in Fig. 1. The ol and B proteins, which are 
expressed by both the type Ia and Ib strains gave rise to dis- 
tinct bands in the high molecular weight region of the stained 
gel and vary in size between the two strains,  in agreement 
with previous results (21, 22, 30, 31, and our unpublished 
data). Antisera to these two proteins did not detect any pro- 
teins in the extracts of the type II and III strains,  as shown 
in the blot (which was deliberatdy overexposed  to demon- 
strate this lack of reactivity). A major protein species in the 
high molecular weight region was present also in the extract 
prepared from the type III strain, although this strain does 
not express the c~ protein or the B protein. Such a distinct 
protein species of high molecular weight was also observed 
in extracts of other type III strains, and the protein appeared 
to vary in size between different strains.  These similarities 
to the o~ and B proteins made it of interest to study the high 
molecular weight proteins of type III strains in more detail. 
Strain BS30 was chosen for this work, because it was known 
to be mouse virulent. The 95-kD protein expressed by this 
strain (Fig. 1) was purified from mutanolysin extracts, using 
two consecutive steps of ion exchange chromatography, fol- 
lowed by gel filtration (Fig.  2). Fractions were analyzed by 
SDS-PAGE for presence of the 95-kD protein. When appro- 
priate fractions from the gel filtration were pooled and ana- 
lyzed, only two protein species were detected: a major 95- 
and a minor 90-kD protein (see inset, Fig. 2 B). The 90-kD 
protein most likely represents  a degradation product of the 
95-kD protein, since these two proteins have the same NH2- 
terminal sequence  (see below). The purified protein will be 
referred to as protein Rib (resistance to proteases, immunity, 
group  B;  see  below).  Antiserum  to  the  95-kD  form  of 
protein Rib was prepared by immunizing rabbits with slices 
cut out from SDS-PAGE  gels. 
Figure 2.  Purification  of protein Rib from the type III strain BS30. 
(A) A mutanolysin  extract, partially  purified  through a previous step of 
DEAE ion exchange  chromatography  (see Materials and Methods) was 
subjected to ion exchange  chromatography  on a 30-ml column  of DEAE 
Bio-Gel A, which was eluted with a linear gradient (800 ml) of NaC1 
in 10 mM Tris, pH 8.0, followed  by 1 M NaC1 (60 ml). (Shaded  area) 
Fractions  containing  protein  Rib. (Inset)  Pool  of  the protein  Rib-containing 
fractions analyzed  by SDS-PAGE. (Left)  Molecular mass markers, are in 
kilodaltons. (Arrow) Position of protein Rib (95 kD). (B) The pool of 
protein Rib-containing  fractions  from  the ion exchange  chromatography 
were subjected  to gel filtration  on a column  (4.2 x 90 cm) of Sepharose 
CL6B. (Shaded  area) Fractions  containing  protein  Rib. (Inset)  Pool  of these 
fractions analyzed  by SDS-PAGE. (/Io) Void volume; (//i) total volume. 
Protein Rib Is Expressed on the Cell Surface  of Most Group 
B Streptococcal Strains of Type III.  To analyze whether pro- 
tein Rib is a cell surface protein, strains representing the four 
major serotypes were tested for ability to bind anti-Pdb serum 
(Fig.  3).  The five strains studied included the four strains 
described above  and an additional type III strain, BM110, 
which is a member of the high-virulence type III clone de- 
scribed by Musser et al. (23). For comparison,  these five strains 
were also tested for expression of the c~ and B proteins, using 
antisera to highly purified preparations of these proteins. 
The anti-~ serum reacted strongly with the Ia and Ib strains, 
as expected, and it also reacted weakly with the two strains 
1596  Streptococcal  Protein Rib 100 
80' 
A 
~'~ 60' 
== 
.c_ 40, 
anti-alpha  serum 
A 
0  ........  - ....  ,  .......  __  .......  I 
10 2  10 3  10 4  10 5  10 0 
antiserum  dilution 
anti-beta  serum  anti-Rib  serum 
lOO. B  1~176 
￿9  la 
80~  ~---------Ir  80-  ~  Ib 
~:~  'k  ----.o---  II 
't'~  N.  .e.  In (BS 30) 
60"  ~  60, k~NN~N,~  "  III (BM110) 
/u 
antiserum  dilution  antiserum  dilution 
with radiolabeled  protein G, and the numbers  on the y-axis refer to the percentage  of protein G bound of that 
rabbit  serum were included  in all experiments  and were completely negative in all cases. 
Figure 3.  Analysis of group B 
streptococcal  strains  of  the  four 
major serotypes for cell surface ex- 
pression of the <x,/3, and Rib pro- 
teins. Five strains were tested: A909 
(type Ia);  SB35 (type  Ib);  B1284 
(type  II);  BS30 (type  III),  and 
BMl10 (type III). (C) Symbols used 
for these five strains. Bacterial sus- 
pensions were incubated  with dif- 
ferent dilutions of rabbit antiserum 
to the cx,/5, or Rib protein,  as in- 
dicated. The numbers on the x-axis 
refer to final antiserum  dilution in 
the bacterial mixture. Bound anti- 
bodies were detected by incubation 
added.  Controls with preimmune 
of type III (Fig. 3 A). However, mutanolysin extracts of the 
type III strains did not contain any detectable el protein, when 
analyzed in a Western blot. It therefore seems likely that this 
weak reactivity of anti-el serum with whole bacteria of type 
III represents a crossreactivity with some other cell wall com- 
ponent. These data show that reactivity with anti-o~ serum 
can be used to unequivocally analyze whether  a strain  ex- 
presses the o~ antigen on the cell surface.  Similar data were 
obtained with  anti-/~  serum  (Fig.  3 B). 
The antiserum to protein Rib reacted with the two type 
III strains, but not with the strains of types Ia and Ib (Fig. 
3 C). An intermediate level of binding was observed for the 
type II strain. When mutanolysin extracts of the five strains 
were analyzed in a Western blot experiment, using anti-Rib 
serum for the analysis, the extracts of the type III strains reacted 
strongly, giving major blotting bands at 95 kD, but the ex- 
tracts of the three other strains completely lacked reactivity 
(data not shown). This result indicates that the intermediate 
reactivity of anti-Rib serum with the type II strain was due 
to a crossreactivity, which disappeared under the conditions 
of the Western blot.  We conclude that  protein  Rib is ex- 
pressed on the cell surface of the two type III strains,  but 
not  on the other  three strains. 
A comparison of A-C, Fig. 3, indicates that  the titer of 
the anti-Rib serum is lower than the titer of the other two 
antisera. Several factors could contribute to such a difference, 
e.g., the concentration of specific antibodies in the sera, the 
a~nity of these antibodies,  the amount of antigen per bac- 
terial cell, etc. To study whether the concentration of anti- 
bodies in the sera contributed to the difference, we measured 
the level of such antibodies,  using a solid-phase RIA with 
the purified antigens immobilized in microtiter wells. The 
data indicated that  the concentration  of specific  antibodies 
was about threefold lower in the anti-Rib serum than in the 
other two antisera (data not shown). This result can at least 
partially explain the difference in titer between the three sera 
in the binding  assay (Fig.  3). 
Since the data in Fig. 3 indicated that protein Rib is found 
on the surface of two different type III strains,  it was of in- 
terest to study a larger number of group B streptococcal strains 
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for expression of this protein. A total of 58 strains of known 
serotype, all of which had been isolated from invasive infec- 
tions, were therefore tested for ability to bind antibodies to 
protein Rib (Table 1). Each strain was also tested for binding 
of antibodies to the el and/3 proteins. To simplify the study 
of many strains,  each antiserum was tested at a single 1,000- 
fold dilution, chosen on the basis of the data shown in Fig. 
3. The results obtained with antiserum  to protein Rib are 
presented in Fig. 4, which shows that the strains can be divided 
into  two populations  with  0-15%  and  21-60%  binding, 
respectively.  Western blot analysis of several bacterial extracts 
confirmed that these two populations correspond to strains 
that do or do not express protein Rib, except that  a single 
strain showing 21% binding did not express the protein (data 
not  shown).  As shown in Table 1, protein Rib was found 
Table  1.  Cell Surface Expression of the or,/~, and Rib 
Proteins by 58 Group B Streptococcal Strains Isolated from 
Patients with Invasive Infections 
Capsular  type 
Protein  Ia  Ib  II  III 
expressed  (n  =  9)  (n  =  3)  (n  =  13)  (n  =  33) 
ot  6  0  4  0 
1  o  o  o 
o~ and  ~  1  3  5  0 
Rib  0  0  1  31 
None  1  0  3  2 
The cell surface expression of the ~, fl, and Rib proteins was analyzed 
with specific antisera,  and bound antibodies were detected with radiola- 
beled protein G, as shown in Figs. 3 and 4. The 58 strains studied here 
were all isolated from cases of invasive infections,  but do not represent 
a random collection of such strains, since most of the type II strains were 
later added to the collection originally studied, which included only two 
type II strains  (see Materials  and Methods). 2~ 
m  H|  C ..............  : 
binding (%) 
Figure  4.  Binding of anti-Rib serum to 58 group B strepmc~:al strains 
isolated from patients with invasive infections. Each strain was tested for 
ability to bind anti-Rib antibodies at a single antiserum dilution (1:1,000). 
Bound antibodies were detected with radiolabeled protein 13. Controls 
with preimmune serum were completely  negative in all cases. 
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Figure  5.  Binding of anti-Rib antibodies to the type III strain BS30 
treated with different agents before the binding assay. The procedure used 
was the same as that used for the experiments shown in Fig.  3,  except 
that the BS30 bacteria was incubated in one of the solutions indicated 
before the binding assay. After incubation for 20 min at room tempera- 
ture, the bacteria were washed three times with PBSAT and analyzed for 
ability to bind anti-Rib serum. 
on the cell surface of 31 out of 33 type III strains  and on 
1 out of 13 type II strains,  but not on any of the 12 strains 
of types Ia and lb. The tests with antisera  to the o~ and/8 
proteins also gave unequivocal results,  and are summarized 
in  Table 1. 
It seemed possible that strains that do not express protein 
Rib on the cell surface excrete the protein into the medium. 
Culture supernatants of the 58 strains listed in Table 1 were 
therefore analyzed in a dot-blot experiment,  using anti-Rib 
serum for the analysis.  Protein Rib was not detected in the 
supernatants of any of the 26 strains that do not express the 
protein on the cell surface, but was found in the supernatants 
of 26 of the 32 strains expressing the protein on the cell sur- 
face (data not shown). Analysis of concentrated culture su- 
pernatants  from two different type III strains  showed that 
protein Rib was one of the major proteins in these superna- 
tants, but >80% of the protein was estimated to be cell bound 
(data not  shown).  The presence of protein  Rib in culture 
supernatants was not unexpected, since it is known that the 
ot and/8 proteins are often found in supernatants  of strains 
expressing these proteins (11, 22, 32). In agreement with these 
reports, we found that most of the strains expressing the o~ 
and/8 proteins (Table 1) released these proteins into the cul- 
ture  medium  (17/19 and 8/10,  respectively). 
The data reported above indicate that protein Rib is a cell 
surface antigen, like the ot and/8 proteins. However, the pos- 
sibility remained that Rib is secreted into the medium and 
unspecifically bound to the bacterial cell surface, giving a posi- 
tive result in the binding assay. To test this hypothesis, we 
treated strain BS30 with different chemicals before the binding 
assay. The result (Fig.  5) shows that not even 6 M  urea had 
any effect on the ability of the cells  to bind antibodies  to 
protein Rib. Additional evidence that  protein Rib is a cell 
surface molecule was obtained in  an experiment  in which 
strain BS30 was treated with proteinase K before mutanolysin 
extraction. Such protease treatment completely removed pro- 
tein Rib from the extract, as shown by Western blot analysis 
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(data not shown). Taken together,  all of these data strongly 
suggest  that  protein  Rib is a cell surface protein. 
We have previously shown that  the B protein is released 
in almost pure form from bacteria incubated at high pH (22). 
When strains expressing protein Rib or the ot protein were 
tested in the same way, such release was not observed (data 
not  shown). 
Protein Rib Confers Protective Immunity.  A mouse protec- 
tion model was used to study whether rabbit antibodies to 
protein Rib can protect against lethal infection with the group 
B Streptococcus (Table 2). Control animals received antiserum 
to the ot protein or preimmune serum, as indicated. The an- 
tiserum to the oz protein had been prepared by the same pro- 
cedure as that used for protein Rib, i.e., by immunizing rabbits 
with  gel slices containing  highly purified protein. 
The data in Table 2 demonstrate that antiserum to protein 
Rib protects against lethal infection with BS30, the type III 
strain from which the protein had been purified.  This pro- 
tection is .not unspecific,  as shown by the experiments with 
control sera.  The anti-Rib serum also protected against le- 
thal infection with another type III strain,  BM110, a member 
of the high-virulence clone of group B streptococcal strains 
(23). In contrast, the anti-Rib serum did not protect against 
infection with L25,  a type III strain  that  does not express 
protein Rib. The protective effect of anti-Rib serum was not 
limited to type III strains,  as shown by the experiments with 
a type II strain expressing protein Rib. Taken together,  the 
data in Tables I and 2 strongly suggest that protein Rib confers 
protective immunity to almost all type III strains and to some 
type II  strains,  i.e.,  to most  group  B  streptococcal strains 
causing  invasive  infections. 
As expected, anti-Rib serum did not protect against infec- 
tion with a type Ib strain, but protection was obtained with 
anti-or  serum (Table 2). Since the SB35 strain used for this 
experiment expresses both the oz and/8 proteins,  this result 
indicates that anti-oz serum can protect against lethal infec- 
tion even if the infecting strain also expresses the/8 protein. Table  2.  Rabbit Antiserum to Protein Rib Protects Mice against 
Lethal Infection with Group B Streptococcal Strains Expressing 
this Protein 
Mice surviving after 
pretreatment with* 
Relevant 
Capsular  cell  surface  Anti-Rib  Anti-a  Normal 
Strain  type  protein  serum  serum  serum 
BS30  III  Rib*  29/32s  1/15  4/20 
BM110  III  Rib  15/24S  0/15  0/15 
L25  III  -  0/15  2/14  ND 
BE210  II  Rib  10/1511  0/14  ND 
SB35sed 1  Ib  a  1/15  10/154  ND 
C3H/HeN mice were injected intraperitoneaUy  with 0.1 ml of rabbit 
antiserum (diluted to 0.5 ml with PBS) and challenged 4 h later with 
an LDg0  doge of log-phase bacteria, diluted into 0.5 ml of Todd-Hewitt 
broth. The survival data were analyzed by the X  2 test. 
* Expression of protein Rib or the ~ protein, the two antigens relevant 
to these experiments. 
* No.  of mice surviving for 4 d/total no.  of infected mice. 
s P <0.001 when compared with the controls receiving anti-~ or nor- 
mal serum. 
II P <0.001 when compared with the controls receiving anti-or serum. 
￿82  P <0.01 when compared  to the controls receiving anti-Rib serum. 
Immunochemical  Comparison of Protein Rib with the cr and 
Proteins.  Since protein Rib confers protective immunity, 
like the c~ and/3 proteins, it was of interest to compare the 
properties of these three proteins. A Western blot experiment 
was first performed, using antisera to the purified proteins 
for the analysis (Fig. 6). Although the staining gel showed 
that the three proteins were highly purified, with one major 
species in each preparation, the immunoblots revealed addi- 
tional bands in each of the three proteins. For the ot protein, 
the blot  showed a ladderlike pattern with regularly spaced 
intervals, as previously described (33-35). This pattern prob- 
ably reflects the repetitive structure of the protein, but the 
mechanism by which the pattern arises is not known  (16). 
A  ladder pattern was not seen in the blot of the B protein, 
but there were a few bands corresponding to proteins of lower 
molecular weight, as noted previously (14). Interestingly, the 
blotting analysis of protein Rib revealed a ladderlike pattern, 
very similar to that seen for the ot protein.  Protein Rib ex- 
tracted from the bacterial cell wall and that present in cul- 
ture  supernatants  gave rise to  similar ladder  patterns  (data 
not  shown).  The distance between the individual  steps  in 
the ladder, which was similar for protein Rib and the ot pro- 
tein, corresponds to a molecular weight difference of about 
9,000. In spite of this similarity, there was no serological cross- 
reaction between the ot and Rib proteins in the Western blot. 
Since this  analysis was  made under  denaturing  conditions, 
a dot-blot test was also performed, in which the native pro- 
teins were tested for crossreactivity. This experiment confirmed 
that the or,/3,  and Rib proteins are serologically unrelated 
(Fig.  7). 
Protein Rib Is Protease Resistant.  The ot and/~ proteins were 
originally distinguished  as two separate components in the 
c antigen, because of a difference in protease sensitivity (11, 
12). The ol protein is resistant to trypsin but sensitive to pepsin, 
whereas the/3 protein is sensitive to both of these proteases. 
An experiment with the purified o~ and/~ proteins confirmed 
this difference and also demonstrated that protein Rib is resis- 
tant to pepsin and relatively resistant to trypsin (Fig. 8). There 
was a shift in the protein Rib pattern after treatment  with 
trypsin, indicating a sensitive site at one end of the molecule, 
but a comparison with the ~  antigen indicates that Rib can 
be classified as relatively trypsin resistant.  As expected,  all 
three proteins were sensitive to degradation by proteinase K 
(data not shown). The protease resistance of protein Rib was 
not due to the presence of an inhibitor,  since B protein was 
Figure 6.  Western  blot analysis  of purified  a, B, and Rib proteins  with 
rabbit antisera raised against the purified proteins. The protein prepara- 
tions used for this analysis had been electroeluted from SDS-PAGE  gels 
(see Materials and Methods). Antisera were used at a 1:1,000 dilution, 
and bound antibodies were detected with radiolabeled  protein G. The au- 
toradiograms were deliberately overexposed,  to visualize the ladder pat- 
tern in the immunoblots of the c~ and Rib proteins. (Left)  Molecular  mass 
markers are in kilodaltons. 
Figure 7.  Dot-blot analysis of purified o~, B, and Rib proteins with 
rabbit antisera raised against the purified  proteins. Bound antibodies  were 
detected with radiolabeled  protein G. The protein preparations used for 
this analysis were the native proteins recovered  after the gel filtration step 
in the purification procedures. Antisera were used at a 1:1,000 dilution. 
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treated with trypsin or pepsin. The trypsin treatment was performed at 
pH 7.5, the pepsin treatment at pH 4.0. The samples were neutralized 
before the SDS-PAGE  analysis. Controls were treated in the same way as 
the samples  containing trypsin or pepsin, but no enzyme was added. Such 
treatment did not cause  degradation of the proteins. The protein prepara- 
tions used for this analysis were the native proteins recovered  after the 
gel filtration step in the purification procedures. (P) Pepsin; (T) trypsin. 
(LeO) Molecular mass markers are in kilodaltons, 
completely degraded by both trypsin and pepsin even in the 
presence of protein  Rib  (data  not  shown). 
Protein Rib  Varies in Size  between Different Group B  Strep- 
tococcal Strains.  Both the ot and 3  proteins vary in size be- 
tween different bacterial strains (Fig.  1). The c~ protein has 
been reported to occur in forms ranging in size from 63 to 
200 kD (30, 35),  and two sequenced variants of the 3  pro- 
tein vary in  size by about  3  kD  (14,  15,  31).  Protein  Rib 
also varies in size between different strains,  as shown by an 
immunoblotting experiment with extracts made from eight 
different type III strains (Fig. 9, lanes I-8).  The size of the 
major protein Rib species varied between 65 and 125 kD in 
these strains. A  ladder pattern similar to that seen with the 
purified protein was observed for protein Rib expressed by 
each of these different strains. 
To study whether the size of protein Rib varies at high 
frequency within an individual strain, five different colonies 
of strain BMll0 were picked and reisolated 10-fold. Culture 
extracts were then prepared and  analyzed by immunoblot- 
ting.  In all cases,  the size of the major protein Rib  species 
was identical in the reisolated strain and in the original strain. 
Similar results were obtained with four other type III strains 
(data  not  shown). 
NHzterminal  Sequences of Protein Rib  and  the o: Protein. 
The NH2-terminal sequences of protein Rib and the c~ pro- 
tein are shown in Fig.  10. The 95- and 90-kD polypeptides 
in  purified protein Rib  (Fig.  2  B) were found to have the 
same  NH2-terminal  sequence,  suggesting  that  the  smaller 
molecule is a degradation product of the larger one. A  data 
search  showed  that  the  NH2-terminal  sequence of protein 
Rib  is  unique. 
Figure  9.  Western  blot analysis with anti-Rib serum of extracts pre- 
pared from different streptococcal  strains. The stained gels (not shown) 
showed that all extracts contained similar amounts of protein. Bound an- 
tibodies were detected  with radiolabeled  protein G. (Lanes  I-8) Mutanolysin 
extracts of  eight different  group B streptococcal  strains of type III. (Lanes 
9-11) Mutanolysin  extracts  of three  group A streptococcal  strains of  different 
M types, of which the M3 and M28 strains express  different R antigens 
(see Materials and Methods). The autoradiograms were deliberately  over- 
exposed, to visualize  the ladder pattern in the blots of the group B strep- 
tococcal extracts. (Left) Molecular mass markers are in kilodahons. 
The  NH2-terminal  sequence  of the  ol protein  (Fig.  10) 
corresponds to residues 57-68 in the published  amino  acid 
sequence, which was deduced from the nucleotide sequence 
of the gene in  strain  A909  (16).  This  result  indicates  that 
the NHz-terminal  sequence of the ~  protein is identical in 
different strains,  and it also suggests  that the a  protein has 
an  unusually  long  signal peptide,  56  residues. 
A  comparison of the NHz-terminal sequences of the Rib 
and a  proteins revealed considerable sequence homology, with 
identical amino  acid residues at 6  out of 12 positions  (Fig. 
10).  In contrast, a comparison of the NH2-terminal sequence 
of protein Rib  with that  of the 3  protein  (14,  15)  did not 
reveal any homology. 
Relationship of  Protein Rib to Streptococcal R Antigens.  The 
R  antigens are a heterogeneous group of cell surface antigens, 
unrelated to virulence,  that  are expressed by certain strains 
of group A  streptococci (26,  36,  37).  Antiserum  to the R 
antigen of type M28 strains also detects an antigen in some 
strains of group B streptococci. This group B  streptococcal 
antigen, which is also designated R, is trypsin resistant, like 
Rib: 
AIpha: 
Ala-  G1  u-Val-  lle-  Ser-Gly Asp-Ala-Val-  Thr-  Leu  -ASh 
I  I  i  t  4  I 
Ser-Thr-Ile-Pro-Gly-Ser  Ala-  X  -Thr-Leu  Asn  Thr- 
Figure  10.  NH2-terminal sequences  of protein Rib and the ~ protein. 
For the o~ protein, residue no. 8 could not be identified and is denoted 
by X. The NH2-terminal sequence of the o~ protein shown here was de- 
termined on material  purified  from strain SB35  and corresponds  to residues 
57-68 in the published amino acid sequence  (16), which was deduced  from 
the nucleotide sequence of the gene in strain A909. The latter sequence 
includes the signal peptide and has an Ala residue at the position marked 
by X here. ([) Residue identities. The one-residue gap at the beginning 
of the ~  sequence was introduced to maximize homology. 
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tigen is not identical to protein Rib, since the R  antigen is 
sensitive to pepsin and does not confer immunity to type III 
strains, unlike protein Rib (36, 38). On the other hand, we 
have noted that antiserum to protein Rib detects a high mo- 
lecular weight protein in extracts of M28 strains, but not 
in extracts of an M3 strain expressing another IL antigen (Fig. 
9). The blotting signal obtained with the M28 extract was 
weaker than those obtained with extracts prepared from group 
B streptococci and the blot did not show a ladder pattern 
even after prolonged exposure of the film. The antigen of 
the M28 strain had a molecular weight of about 180,000, 
larger than protein Rib expressed  by any of the group B strains 
tested, and it was of similar size in two different M28 strains 
tested. These results indicate that protein Rib crossreacts  with 
a large antigen expressed by M28 strains, possibly the R an- 
tigen of those strains. Further analysis of this crossreactivity 
has not yet been possible, since the tt antigens have not been 
purified and monospecific antisera to these antigens are not 
available. Howev~, an antiserum to whole M28 bacteria reacted 
with protein Rib,  as expected (data not shown). 
Discussion 
Previous work has shown that two different cell surface 
proteins, the o~ and/3 proteins, confer protective immunity 
to group B streptococcal infection (10, 11, 19, 20), but the 
importance of these proteins in serious infections has remained 
unclear, since they are only rarely expressed by strains of sero- 
type III (10, 17, 18). In contrast, the novel cell surface pro- 
tein described here, protein Rib, is expressed by almost all 
type III strains, including two strains that are known to be 
members of a high-virulence done (23). This finding allows 
us to conclude that most invasive strains of the group B Strep- 
tococcus express two different antigens that confer protective 
immunity: the type-spedfic polysaccharide capsule (1) and 
a cell surface protein.  The relative importance of these two 
antigens is not known, but it is noteworthy that the pres- 
ence of antibodies to only one of the two antigens is sufficient 
to protect against lethal infection (10), which suggests that 
both the polysaccharide and the protein antigen may be re- 
quired for virulence. 
Protein Rib is a cell surface protein of high molecular 
weight, like the cr and/3 proteins, but it is immunologically 
unrelated to these two proteins. However, protein Rib and 
the a  protein share several other properties.  First, both the 
c~ and Rib proteins  are relatively resistant to trypsin diges- 
tion. For the ol protein, this resistance is not due to a lack 
of potentially trypsin-sensitive sites, but must be due to some 
other property of the molecule (16). Protein Rib is actually 
even more protease resistant than the ol protein, since it is 
also resistant to pepsin. This protease resistance of the Rib 
and o~ proteins  may contribute to the ability of the group 
B Streptococcus to avoid the unspecific defense mechanisms of 
the host. A second similarity between the a  and Rib pro- 
teins is the great variation in size between proteins expressed 
by different bacterial isolates (30, 35). This size variation can 
most simply  be explained  by a variation  in the number of 
repeating  units  (16),  as  described  for  the  group  A streptococcal 
M6 protein  (39).  Finally,  both the a and Rib proteins  ex- 
hibit  a ladderlike  pattern  in immunoblotting experiments. 
For  the  cr  protein,  which  is  a  molecule  with  a  highly  repeti- 
tive  structure  (16),  the  distance  between  the  steps  in  this  ladder 
corresponds  to the  deduced molecular  weight of  the  repeat 
region, but the mechanism by which the ladder pattern is 
generated  is not understood (16). The similarity between the 
immunoblots of the c~ and Rib proteins suggests that both 
of these proteins  may have a highly repetitive  structure. 
The Rib and o~ proteins exhibit considerable sequence ho- 
mology in the NH2-terminal region, which indicates that 
they have evolved from a common ancestor. This sequence 
similarity and the other similarities between the two mole- 
cules suggest that the Rib and ot proteins  are members of 
a family of proteins  with related structure and properties, 
although they are immunologically  unrelated. An analogous 
situation has recently been described in the group A strep- 
tococcal M protein family, which can be divided into two 
major classes of immunologically unrelated molecules (40). 
In this connection it should also be noted that protein Rib 
crossreacts with a protein expressed by M28  strains of the 
group A Streptococcus, possibly the IL antigen of those strains 
(Fig. 9). This crossreacting protein might also be a member 
of the hypothetical family that includes the Rib and c~ pro- 
teins. Work is in progress to make a more detailed compar- 
ison of the structure and properties of these different proteins. 
About 20% of all women are vaginal carriers of the group 
B Streptococcus,  and vertical transmission from the maternal 
genital tract is probably the most common source of infec- 
tion in neonatal disease caused by this bacterium (1). How- 
ever, only 1-2% of  the infants that are colonized by the group 
B  Streptococcus  at birth are afflicted by serious infection (1, 
2). Other factors than exposure to the bacterium during birth 
must therefore contribute to the development of neonatal dis- 
ease. An understanding of these factors will be essential to 
finding ways of prevention of group B streptococcal disease. 
It has been reported that mothers of infected infants have 
significantly lower levels of antibodies  to the type III cap- 
sule, which implies that these antibodies are important for 
protection against neonatal disease (41), but this issue is con- 
troversial (2, 3). It has also been suggested that maternal an- 
tibodies to bacterial cell surface proteins may be important 
for protective immunity (42, 43). The properties of protein 
Rib indeed suggest that the level of antibodies to this pro- 
tein may affect the susceptibility  to group B streptococcal 
disease in the neonate. Studies are in progress to test this hy- 
pothesis. 
In summary, we have found a novel cell surface protein 
that is expressed by almost all group B streptococcal strains 
of serotype III and that confers protective immunity. The 
available evidence indicates that protein Rib is structurally 
related to the cz antigen, and a more detailed comparison of 
these two cell surface proteins is therefore of interest for the 
analysis of pathogenetic mechanisms in group B streptococcal 
infections. Characterization  of the Rib and c~ proteins may 
also yield information that is of interest  for studies of cell 
1601  Stilhammar-Carlemalm  et al. surface proteins expressed by other encapsulated bacteria, e.g., 
the Pneumococcus  (44). With regard to prevention of group 
B streptococcal disease, it seems possible that a combination 
of the Rib and cr proteins could be used for the development 
of a vaccine,  since the large majority of virulent  strains ex- 
press one of these two proteins.  One advantage with a vac- 
cine based on proteins, rather than on polysaccharides, might 
be absence of immunological crossreactions with human gly- 
coproteins  (45). 
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